Seeing Is Believing
CNTA is currently covered by 6 analysts with an average price target of $22.73. This is a potential upside of $5.69 (33.39%) from yesterday's end of day stock price of $17.04.
Centessa Pharmaceuticals PLC ADR's activity chart (see below) currently has 18 price targets and 30 ratings on display. The stock rating distribution of CNTA is 11.11% SELL, 55.56% BUY and 33.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 61.9% with an average time for these price targets to be met of 205.43 days.
Highest price target for CNTA is $35, Lowest price target is $26, average price target is $22.73.
Most recent stock forecast was given by DEBJIT CHATTOPADHYAY from GUGGENHEIM on 15-Nov-2024. First documented stock forecast 22-Jun-2021.
Currently out of the existing stock ratings of CNTA, 2 are a SELL (11.11%), 10 are a BUY (55.56%), 6 are a HOLD (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$28
$10.96 (64.32%)
$24
9 days ago
(15-Nov-2024)
2/4 (50%)
$10.84 (63.17%)
213
Hold
$26
$8.96 (52.58%)
$11
2 months 4 days ago
(20-Sep-2024)
6/9 (66.67%)
$9.42 (56.82%)
306
Buy
$35
$17.96 (105.40%)
$20
2 months 8 days ago
(16-Sep-2024)
3/6 (50%)
$18.54 (112.64%)
378
Hold
$5
$-12.04 (-70.66%)
$4.5
1 years 3 months 9 days ago
(15-Aug-2023)
2/4 (50%)
$-1.91 (-27.64%)
3
Hold
$5
$-12.04 (-70.66%)
$4.5
1 years 3 months 9 days ago
(15-Aug-2023)
2/3 (66.67%)
$-1.91 (-27.64%)
385
What is CNTA (Centessa Pharmaceuticals PLC ADR) average time for price targets to be met?
Which analyst has the current highest performing score on CNTA (Centessa Pharmaceuticals PLC ADR) with a proven track record?
Which analyst has the current lower performing score on CNTA (Centessa Pharmaceuticals PLC ADR) with a proven track record?
Which analyst has the most public recommendations on CNTA (Centessa Pharmaceuticals PLC ADR)?
Which analyst is the currently most bullish on CNTA (Centessa Pharmaceuticals PLC ADR)?
Which analyst is the currently most reserved on CNTA (Centessa Pharmaceuticals PLC ADR)?